The double-edge sword of CRISPR application for in vivo studies
“The Achilles’ heel of CRISPR application is the delivery of sgRNA/Cas9 to the desired tissues.”
BUFFALO, NY- November 28, 2023 – A new editorial paper was published in Oncotarget's Volume 14 on November 27, 2023, entitled, “The double-edge sword of CRISPR application for in vivo studies.”
In this new paper, researcher Martin K. Thomsen from Aarhus University begins his editorial by discussing a hallmark paper that was published a decade ago by Platt et al. on the in vivo ...














